Why Is ESTABLISHMENT LABS H (ESTA) Stock Up Today?

Establishment Labs Holdings stock rose 7.96% to $62.49 on Tuesday, driven by a new Buy rating from Stifel and a reiterated Buy from TD Cowen ahead of a key FDA decision. The shares also printed 12 fresh 52-week highs during the session, reflecting strong momentum despite a modest volume print.

What Happened

Stifel initiated coverage of Establishment Labs with a Buy rating and a price target of $85. Separately, TD Cowen reiterated its Buy rating on the stock, maintaining a price target of $117 ahead of an upcoming FDA decision. The company also filed an 8-K with the SEC on October 15, 2026, disclosing the entry into a material definitive agreement. This filing included financial statements and exhibits. In related news, Establishment Labs extended its master supply agreement with NuSil Technology to December 31, 2031. The company also announced that the FDA approved 28 new sizes of Motiva breast implants, which are available before year-end. Additionally, Establishment Labs is scheduled to present new breast tissue preservation data and announce minimally invasive product extensions at the 11th World Symposium on Ergonomic Implants.

What The Data Shows

The stock opened at $57.25, a 1.1% gap down from the prior close of $57.88. The session low was $57.25 at 7:25 AM ET, while the session high reached $62.77 at 10:55 AM ET. Volume stood at 0.1 million shares, which is 0.2 times the three-month daily average. The company has a market capitalization of $1.7 billion and is currently unprofitable, with a trailing twelve-month EPS of $1.29. Revenue grew 38.6% over the trailing twelve months, though the net margin stands at 15.8%. The stock has a beta of 1.06 and a 52-week range of $40.59 to $97.59. The 30-day average sentiment score is 64 out of 100, while the last seven days average is 60 out of 100, indicating a slight deterioration in recent sentiment.

What To Watch

Investors will monitor the upcoming FDA decision, which is a primary driver for the current analyst ratings. The company’s presentation at the 11th World Symposium on Ergonomic Implants will also provide further details on its product extensions and data.